EWTX
Price
$48.35
Change
+$2.05 (+4.43%)
Updated
Jul 9 closing price
Capitalization
5.2B
27 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$24.16
Change
+$0.15 (+0.62%)
Updated
Jul 9 closing price
Capitalization
2.74B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EWTX vs IMNM

EWTX vs IMNM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EWTX vs. IMNM commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Buy and IMNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2026
Stock price -- (EWTX: $48.35 vs. IMNM: $24.16)
Brand notoriety: EWTX and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 58% vs. IMNM: 54%
Market capitalization -- EWTX: $5.2B vs. IMNM: $2.74B
EWTX [@Biotechnology] is valued at $5.2B. IMNM’s [@Biotechnology] market capitalization is $2.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $126.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, EWTX is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • EWTX’s TA Score: 5 bullish, 4 bearish.
  • IMNM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, EWTX is a better buy in the short-term than IMNM.

Price Growth

EWTX (@Biotechnology) experienced а +22.22% price change this week, while IMNM (@Biotechnology) price change was +2.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.23%. For the same industry, the average monthly price growth was +13.67%, and the average quarterly price growth was +1900.19%.

Reported Earning Dates

EWTX is expected to report earnings on Aug 06, 2026.

IMNM is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+1.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($5.2B) has a higher market cap than IMNM($2.74B). EWTX YTD gains are higher at: 94.842 vs. IMNM (12.453). EWTX has higher annual earnings (EBITDA): -197.26M vs. IMNM (-235.83M). IMNM has more cash in the bank: 583M vs. EWTX (500M). IMNM (3.69M) and EWTX (3.79M) have identical debt. IMNM has higher revenues than EWTX: IMNM (4.02M) vs EWTX (0).
EWTXIMNMEWTX / IMNM
Capitalization5.2B2.74B190%
EBITDA-197.26M-235.83M84%
Gain YTD94.84212.453762%
P/E RatioN/AN/A-
Revenue04.02M-
Total Cash500M583M86%
Total Debt3.79M3.69M103%
TECHNICAL ANALYSIS
Technical Analysis
EWTXIMNM
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 25 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
EWTX
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QVOY29.980.35
+1.19%
Q3 All-Season Active Rotation ETF
GRNY27.750.22
+0.80%
Fundstrat Granny Shots US Large Cap ETF
AMZU31.18N/A
N/A
Direxion Daily AMZN Bull 2X Shares
BSVO29.19N/A
N/A
EA Bridgeway Omni Small-Cap Value ETF
QQQT18.05N/A
N/A
Defiance Nasdaq 100 Income Target ETF